We are analyzing https://link.springer.com/article/10.1007/s11914-025-00920-7.

Title:
Oxygen Sensing in Osteocytes: From Physiology to Age-related Osteoporosis | Current Osteoporosis Reports
Description:
Purpose of The Review The purpose of this review article is to discuss how oxygen sensing mechanisms regulate the expression of key osteocyte markers such as podoplanin (E11), sclerostin (SOST), receptor activator of nuclear factor-κB ligand (RANKL), and fibroblast growth factor 23 (FGF23); summarize the relevance of targeting oxygen sensing pathways in osteocytes to improve bone health; and highlight the importance of osteocyte oxygen sensing mechanisms in maintaining good bone health during aging. Recent Findings Oxygen sensing in osteocytes regulates osteocyte dendrites formation, bone mass and mineral metabolism through the regulation of E11, SOST, RANKL, and FGF23. Hypoxia Induced Factor (HIF) stabilization in osteocytes increases the activity of the histone deacetylase SIRT1 which represses SOST expression and increases the expression of FGF23. These recent findings suggest that targeting oxygen-associated pathways can be leveraged to control osteo-anabolic response and mineral metabolism. Aging is associated with the increase of circulating SOST; therefore, the mechanisms associated with SOST overproduction in bone may be linked to age-related changes in oxygen sensing in osteocytes. Summary Understanding the changes of oxygen sensing mechanisms in osteocytes during aging may offer a therapeutic avenue to control SOST overproduction, a negative regulator of bone formation and therefore prevent age-related bone loss. We discuss how oxygen-sensing controls osteocyte physiology and how aging-mediated dysregulation of oxygen bioavailability promotes osteoporosis. We also explore how oxygen-modulating therapies can be used to improve bone healthspan.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

pubmed, article, google, scholar, bone, cas, central, oxygen, osteocyte, osteocytes, sensing, sost, aging, regulation, osteoporosis, formation, hifalpha, res, cell, agoro, mechanisms, expression, fgf, hypoxia, sirt, content, agerelated, rankl, targeting, sci, biol, protein, lee, privacy, cookies, pathways, regulator, mol, zhang, nature, bonewald, rep, kim, springer, data, information, publish, research, search, current,

Topics {✒️}

hypoxia-inducible factor-prolyl hydroxylases controlling hypoxia-inducible factor-2alpha month download article/chapter nuclear factor-κb ligand treat age-related osteoporosis hypoxia-sensing mouse model hypoxia induced factor control osteo-anabolic response shear-stress-induced angiogenesis defective tgf-beta signaling hyperbaric oxygen therapy osteocytic oxygen sensing hypoxia inducible factors article janeczko age-related osteoporosis full article pdf osteocyte dendrites formation hif-1α stabilization oxygen sensing contributes rafiou agoro oxygen sensing mechanisms pathways controlling formation privacy choices/manage cookies molecular hypoxia sensors hypoxia research mlo-y4 cells bone formation inhibitor e11/podoplanin protein stabilization accepted manuscript version age-related phenotypes solid tumor formation current mouse models oxygen-modulating therapies oxygen-dependent enzymes key osteocyte markers trends biochem sci maintaining bone homeostasis hif-2alpha play recent findings suggest fracture healing chronic kidney disease van den ende cobre grant p30gm154610 improve bone health increased bone density osteocyte dendrite network hif signaling pathways methods mol biol central role defective placental vasculogenesis

Questions {❓}

Hypoxia research, where to now?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Oxygen Sensing in Osteocytes: From Physiology to Age-related Osteoporosis
         description:The purpose of this review article is to discuss how oxygen sensing mechanisms regulate the expression of key osteocyte markers such as podoplanin (E11), sclerostin (SOST), receptor activator of nuclear factor-κB ligand (RANKL), and fibroblast growth factor 23 (FGF23); summarize the relevance of targeting oxygen sensing pathways in osteocytes to improve bone health; and highlight the importance of osteocyte oxygen sensing mechanisms in maintaining good bone health during aging. Oxygen sensing in osteocytes regulates osteocyte dendrites formation, bone mass and mineral metabolism through the regulation of E11, SOST, RANKL, and FGF23. Hypoxia Induced Factor (HIF) stabilization in osteocytes increases the activity of the histone deacetylase SIRT1 which represses SOST expression and increases the expression of FGF23. These recent findings suggest that targeting oxygen-associated pathways can be leveraged to control osteo-anabolic response and mineral metabolism. Aging is associated with the increase of circulating SOST; therefore, the mechanisms associated with SOST overproduction in bone may be linked to age-related changes in oxygen sensing in osteocytes. Understanding the changes of oxygen sensing mechanisms in osteocytes during aging may offer a therapeutic avenue to control SOST overproduction, a negative regulator of bone formation and therefore prevent age-related bone loss. We discuss how oxygen-sensing controls osteocyte physiology and how aging-mediated dysregulation of oxygen bioavailability promotes osteoporosis. We also explore how oxygen-modulating therapies can be used to improve bone healthspan.
         datePublished:2025-06-21T00:00:00Z
         dateModified:2025-06-21T00:00:00Z
         pageStart:1
         pageEnd:11
         sameAs:https://doi.org/10.1007/s11914-025-00920-7
         keywords:
            Osteocyte
            Oxygen Sensing
            Osteoporosis
            Aging
            Orthopedics
            Epidemiology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11914-025-00920-7/MediaObjects/11914_2025_920_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11914-025-00920-7/MediaObjects/11914_2025_920_Fig2_HTML.png
         isPartOf:
            name:Current Osteoporosis Reports
            issn:
               1544-2241
               1544-1873
            volumeNumber:23
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Kathryn Janeczko
               affiliation:
                     name:The Jackson Laboratory
                     address:
                        name:The Jackson Laboratory, Bar Harbor, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rafiou Agoro
               affiliation:
                     name:The Jackson Laboratory
                     address:
                        name:The Jackson Laboratory, Bar Harbor, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Oxygen Sensing in Osteocytes: From Physiology to Age-related Osteoporosis
      description:The purpose of this review article is to discuss how oxygen sensing mechanisms regulate the expression of key osteocyte markers such as podoplanin (E11), sclerostin (SOST), receptor activator of nuclear factor-κB ligand (RANKL), and fibroblast growth factor 23 (FGF23); summarize the relevance of targeting oxygen sensing pathways in osteocytes to improve bone health; and highlight the importance of osteocyte oxygen sensing mechanisms in maintaining good bone health during aging. Oxygen sensing in osteocytes regulates osteocyte dendrites formation, bone mass and mineral metabolism through the regulation of E11, SOST, RANKL, and FGF23. Hypoxia Induced Factor (HIF) stabilization in osteocytes increases the activity of the histone deacetylase SIRT1 which represses SOST expression and increases the expression of FGF23. These recent findings suggest that targeting oxygen-associated pathways can be leveraged to control osteo-anabolic response and mineral metabolism. Aging is associated with the increase of circulating SOST; therefore, the mechanisms associated with SOST overproduction in bone may be linked to age-related changes in oxygen sensing in osteocytes. Understanding the changes of oxygen sensing mechanisms in osteocytes during aging may offer a therapeutic avenue to control SOST overproduction, a negative regulator of bone formation and therefore prevent age-related bone loss. We discuss how oxygen-sensing controls osteocyte physiology and how aging-mediated dysregulation of oxygen bioavailability promotes osteoporosis. We also explore how oxygen-modulating therapies can be used to improve bone healthspan.
      datePublished:2025-06-21T00:00:00Z
      dateModified:2025-06-21T00:00:00Z
      pageStart:1
      pageEnd:11
      sameAs:https://doi.org/10.1007/s11914-025-00920-7
      keywords:
         Osteocyte
         Oxygen Sensing
         Osteoporosis
         Aging
         Orthopedics
         Epidemiology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11914-025-00920-7/MediaObjects/11914_2025_920_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11914-025-00920-7/MediaObjects/11914_2025_920_Fig2_HTML.png
      isPartOf:
         name:Current Osteoporosis Reports
         issn:
            1544-2241
            1544-1873
         volumeNumber:23
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Kathryn Janeczko
            affiliation:
                  name:The Jackson Laboratory
                  address:
                     name:The Jackson Laboratory, Bar Harbor, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rafiou Agoro
            affiliation:
                  name:The Jackson Laboratory
                  address:
                     name:The Jackson Laboratory, Bar Harbor, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Current Osteoporosis Reports
      issn:
         1544-2241
         1544-1873
      volumeNumber:23
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:The Jackson Laboratory
      address:
         name:The Jackson Laboratory, Bar Harbor, USA
         type:PostalAddress
      name:The Jackson Laboratory
      address:
         name:The Jackson Laboratory, Bar Harbor, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Kathryn Janeczko
      affiliation:
            name:The Jackson Laboratory
            address:
               name:The Jackson Laboratory, Bar Harbor, USA
               type:PostalAddress
            type:Organization
      name:Rafiou Agoro
      affiliation:
            name:The Jackson Laboratory
            address:
               name:The Jackson Laboratory, Bar Harbor, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:The Jackson Laboratory, Bar Harbor, USA
      name:The Jackson Laboratory, Bar Harbor, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(227)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.42s.

LINK . SPRINGER . COM {}